Latest Cancer Research Stories
The FNIH announces the NFL has agreed to donate $30 million in support of research on serious medical conditions prominent in athletes and relevant to the general population. Bethesda, MD (PRWEB) September 05, 2012 The Foundation for the National Institutes of Health (FNIH) announces that the National Football League (NFL) has agreed to donate $30 million in support of research on serious medical conditions prominent in athletes and relevant to the general population. This is the...
TORONTO, Sept. 6, 2012 /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative and proprietary immune-based biologics, today announced that preliminary results from its preclinical anti-CD47 oncology program have been published in the prestigious Journal of Experimental Medicine (Theocharides et al., published online Sep 3, 2012) The work was conducted in the laboratories of Trillium collaborators Drs. Jean Wang and John Dick at University...
ROCKVILLE, Md., Sept. 6, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today the publication of an article by Ursula A. Matulonis, MD, of Dana-Farber Cancer Institute in Boston, entitled "ENMD-2076, an Oral Inhibitor of Angiogenic and Proliferation Kinases, Has Activity in Recurrent, Platinum Resistant Ovarian Cancer," in the European Journal of Cancer. (Logo:...
--In Genome-Wide Study, Researchers at The Children's Hospital of Philadelphia Uncover New Clues to a Childhood Cancer-- PHILADELPHIA, Sept. 4, 2012 /PRNewswire-USNewswire/ -- Researchers have discovered two gene variants that raise the risk of the pediatric cancer neuroblastoma. Using automated technology to perform genome-wide association studies on DNA from thousands of subjects, the study broadens understanding of how gene changes may make a child susceptible to this early...
Researchers at Rice, Tel Aviv and Johns Hopkins universities aim to break cancer's codes for social networking In the face of mounting evidence that cancer cells communicate, cooperate and even engage in collective decision-making, biophysicists and cancer researchers at Rice University, Tel Aviv University and Johns Hopkins University are suggesting a new strategy for outsmarting cancer through its own social intelligence. "We need to get beyond the notion that cancer is a random...
DURHAM, N.C., Aug. 30, 2012 /PRNewswire/ -- GeneCentric announced today that it has been launched with two separate exclusive licenses to diagnostic technologies from the University of North Carolina at Chapel Hill. The company was co-founded in 2011 by two pioneers in cancer research, Drs. Charles Perou and Neil Hayes, who discovered molecular signatures critical in distinguishing clinically relevant subtypes of lung cancer. GeneCentric in-licensed the Lung Subtype Platform...
University of Colorado Cancer Center remains in distinguished company having received a prestigious designation from the National Cancer Institute (NCI). This is the fourth time the CU Cancer Center has been named a Comprehensive Cancer Center by the NCI – one of only 41 cancer centers in the United States to receive the designation. Aurora, Colo. (PRWEB) August 27, 2012 University of Colorado Cancer Center remains in distinguished company having received a prestigious designation from...
EXTON, Pa., Aug. 27, 2012 /PRNewswire/ -- Morphotek(®), Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma. MORAb-004 is a monoclonal antibody that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1). MORAb-004 is thought to function as an inhibitor of the tumor microenvironment. TEM-1 is thought...
SEATTLE, Aug. 27, 2012 /PRNewswire-USNewswire/ -- Since its opening in 2008, the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment (the Ivy Center) at Swedish Medical Center's Neuroscience Institute has led the expansion drive of major research projects and expanded treatment options for patients living with brain cancer in the Pacific Northwest and throughout the world. The Ivy Center was founded in 2008 to create a world-class treatment and research facility...
Primetime fundraising event to air Sept. 7 simultaneously on ABC, CBS, FOX, NBC and cable channels SCOTTSDALE, Ariz., Aug. 23, 2012 /PRNewswire-USNewswire/ -- Physicians and staff from the Virginia G. Piper Cancer Center at Scottsdale Healthcare will mingle with Hollywood A-listers during the live, primetime television broadcast of the Stand Up To Cancer (SU2C) fundraising telethon on Sept. 7. (Logo: http://photos.prnewswire.com/prnh/20120823/DC62223LOGO ) Virginia G. Piper...
